Oncology
How blood tests can inform cancer treatment decisions, with ...
Craig Eagle, chief medical officer of Guardant Health, discusses blood as a rich source of biomarker development in cancer prognosis.
News
SanegeneBio raises $110m for RNAi, plus other financings
Biotech financings this week include SanegeneBio's Lilly-backed $110m Series B, with Sidera, D3 Bio, BlossomHill, and Prolynx also raising new funds.
News
Pfizer makes first-line case for Tukysa in breast cancer
Pfizer's Tukysa looks poised to find a new role as first-line maintenance therapy for HER2-positive metastatic breast cancer.
News
Roche delivers its data reveal for adjuvant giredestrant
Roche reveals the data that has it excited about giredestrant in early-stage breast cancer, but how might it be positioned versus CDK4/6 inhibitors?
News
FDA set to raise bar for clinical trials of CAR-T therapies
The FDA could make it harder for developers of CAR-T therapies to bring them to market by requiring full randomised controlled trials.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
